Abstract
Breakthrough-Therapy Designation The authors provide a perspective on the rationale and goals of the designation of “breakthrough therapy” by the Food and Drug Administration.
Cite
CITATION STYLE
APA
Corrigan-Curay, J., McKee, A. E., & Stein, P. (2018). Breakthrough-Therapy Designation — An FDA Perspective. New England Journal of Medicine, 378(15), 1457–1458. https://doi.org/10.1056/nejmc1801222
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free